Alvotech ALVO
NASDAQ ALVO
$5.32 -0.06 (-1.12%)
At close: Sep 4, 2026 · 4:00 PM EDT

Alvotech (ALVO) Cash & Current Investments (2020 - 2026)

Alvotech's (ALVO) quarterly Cash & Current Investments came in at $142.8 million in Q2 2026, down 5.75% on a YoY basis from $151.5 million in Q2 2025, and up 123.63% quarter-over-quarter from $63.8 million in Q1 2026.

Analysis

Alvotech (ALVO) Cash & Current Investments (2020 - 2026) Analysis & Trends

Alvotech (ALVO) has reported Cash & Current Investments for 7 consecutive years, with $142.8 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Cash & Current Investments fell 5.75% year-over-year to $142.8 million; the trailing twelve-month figure through Jun 2026 stood at $142.8 million (down 5.75% YoY), and the FY2025 full-year result was $172.4 million, up 235.15% from the prior year.
  • Cash & Current Investments rose to $142.8 million in Q2 2026 per ALVO's latest filing, from $63.8 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $172.4 million in Q4 2025 and bottomed at $10.9 million in Q2 2024.
  • Historically, Cash & Current Investments has averaged $81.8 million across 5 years, with a median of $64.3 million in 2024.
  • The sharpest annual moves came in 2023 and 2025: Cash & Current Investments plunged 83.2% in 2023, then soared 1283.88% in 2025.
  • Over 5 years, Cash & Current Investments stood at $66.4 million in 2022, then plunged by 83.2% to $11.2 million in 2023, then jumped by 360.95% to $51.4 million in 2024, then surged by 235.15% to $172.4 million in 2025, then decreased by 17.18% to $142.8 million in 2026.
  • According to Business Quant data, Cash & Current Investments over the past three periods registered $142.8 million, $63.8 million, and $172.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn 3.66 Bn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn 886.50 Mn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn 171.67 Mn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn 127.64 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn 1.84 Bn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn 360.25 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn 142.75 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn 290.12 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn 41.25 Mn
10 NutriBand 72.57 Mn 69.15 Mn 181,874.00 3.42 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 142.75 Mn
Mar 31, 2026 63.83 Mn
Dec 31, 2025 172.36 Mn
Sep 30, 2025 51.43 Mn
Jun 30, 2025 151.45 Mn
Mar 31, 2025 51.43 Mn
Dec 31, 2024 51.43 Mn
Sep 30, 2024 118.27 Mn
Jun 30, 2024 10.94 Mn
Mar 31, 2024 64.81 Mn
Dec 31, 2023 11.16 Mn
Jun 30, 2023 60.47 Mn
Dec 31, 2022 66.43 Mn
Jun 30, 2022 128.44 Mn
Dec 31, 2021 17.56 Mn
Dec 31, 2020 31.69 Mn